English
Home > News > Industry News

Industry News

Difelikefalin-The first FDA-approved drug for the treatment of chronic kidney disease (CKD)-related pruritus-Difelikefalin injection

Difelikefalin-The first FDA-approved drug for the treatment of chronic kidney disease (CKD)-related pruritus-Difelikefalin injection

The approval of Difelikefalin is an important milestone in the clinical treatment of chronic kidney disease-related pruritus.

Read More
Lifitegrast

Lifitegrast

English name：​Lifitegrast Chemical name：​(S)-2-(2-(benzofuran-6-carbonyl)-5,7-dichloro-1,2,3,4-tetrahydroisoquinoline-6-carboxamido)-3-(3-(methylsulfonyl)phenyl)propanoic acid CAS： 1025967-78-5 Original research company: Shire Pharmaceutical Company, UK Trade name：Xiidra Registration ......

Read More
<1>
Hit enter to search or ESC to close
X
We use cookies to offer you a better browsing experience, analyze site traffic and personalize content. By using this site, you agree to our use of cookies. Privacy Policy
Reject Accept